RxDoctor Payments Data

Khalid Chaudhry, MD

Psychiatry · Fond du Lac, WINPI 1104921766

Payments from drug & device makers

$2,003in general payments, 2019–2025

Across 104 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$596
  • Johnson & Johnson$255
  • Lundbeck LLC$252
  • AbbVie$244
  • Indivior Inc.$117
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$99
  • plus $440 from 9 others

What the payments were for

  • Food & beverage$1,85493%
  • Education$1497%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,003 in reported general payments places this provider in the 85th percentile of 543 psychiatry providers in Wisconsin.

See all psychiatry providers in Wisconsin

Medicare billing

Part B allowed, 2024
$39,082
Medicare patients
114
Services billed
812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl18$28,290
Fluphenazine Hcl107$26,016
RexultiBrexpiprazole16$23,418
Chlorpromazine Hcl22$9,886
VyvanseLisdexamfetamine Dimesylate18$9,327
Oxcarbazepine210$8,811
Paliperidone ErPaliperidone40$7,018
Fluvoxamine Maleate ErFluvoxamine Maleate19$6,338
Aripiprazole178$5,536
Clozapine90$5,535
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine59$5,400
Quetiapine Fumarate196$3,410
Fluphenazine Decanoate28$2,954
Ziprasidone Hcl74$2,816
Prazosin Hcl100$2,745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$244$28,29018 claims
Otsuka America Pharmaceutical, Inc.Rexulti$53$23,41816 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$91$9,32718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 543 psychiatry providers in Wisconsin.

Other psychiatry in Fond du Lac

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →